Advances in antiarrhythmic drug treatment of atrial fibrillation: where do we stand now?

This publication has 16 references indexed in Scilit:

• A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
  New England Journal of Medicine, 2002
• A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
  New England Journal of Medicine, 2002
• Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation
  Circulation, 2002
• Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation
  The American Journal of Cardiology, 2001
• Prevalence of Diagnosed Atrial Fibrillation in Adults
  JAMA, 2001
• Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial
  Published by Elsevier ,2000
• Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter
  Circulation, 2000
• Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation
  Journal of the American College of Cardiology, 2000
• Trandolapril Reduces the Incidence of Atrial Fibrillation After Acute Myocardial Infarction in Patients With Left Ventricular Dysfunction
  Circulation, 1999
• The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
  Circulation, 1991